Follow the 대웅 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 대웅 has published 16 reports. The latest transaction was filed on 26 February 2026 (Other). Among the most active insiders: 대웅. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
1 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.